Literature DB >> 22479048

Current-oasis: a potential mirage of numbers.

Tifaine Magnusson1, Aaron M Tejani.   

Abstract

Year:  2011        PMID： 22479048      PMCID： PMC3093427          DOI： 10.4212/cjhp.v64i2.1003

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  4 in total

1.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.

Authors:  Xin Sun; Matthias Briel; Stephen D Walter; Gordon H Guyatt
Journal:  BMJ       Date:  2010-03-30

2.  Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

Authors:  Shamir R Mehta; Jean-Pierre Bassand; Susan Chrolavicius; Rafael Diaz; John W Eikelboom; Keith A A Fox; Christopher B Granger; Sanjit Jolly; Campbell D Joyner; Hans-Jurgen Rupprecht; Petr Widimsky; Rizwan Afzal; Janice Pogue; Salim Yusuf
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

3.  Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Authors:  Shamir R Mehta; Jean-Francois Tanguay; John W Eikelboom; Sanjit S Jolly; Campbell D Joyner; Christopher B Granger; David P Faxon; Hans-Jurgen Rupprecht; Andrzej Budaj; Alvaro Avezum; Petr Widimsky; Philippe Gabriel Steg; Jean-Pierre Bassand; Gilles Montalescot; Carlos Macaya; Giuseppe Di Pasquale; Kari Niemela; Andrew E Ajani; Harvey D White; Susan Chrolavicius; Peggy Gao; Keith A A Fox; Salim Yusuf
Journal:  Lancet       Date:  2010-10-09       Impact factor: 79.321

Review 4.  Do multiple outcome measures require p-value adjustment?

Authors:  Ronald J Feise
Journal:  BMC Med Res Methodol       Date:  2002-06-17       Impact factor: 4.615
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.